Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations

Journal of Neuroimmunology

Volumn 76, Issue 1-2, 1997, Pages 15-28

  Wilson, Darcy B ^a   Golding, Anna B ^a   Smith, Richard A ^b   Dafashy, Tanya ^b   Nelson, James ^b   Smith, Larry ^c   Carlo, Dennis J ^c   Brostoff, Steven W ^c   Gold, Daniel P ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b Neurology Center   (United States)

^c Orchestra Therapeutics Inc   (United States)

Author keywords

Multiple sclerosis; Regulatory immune response; T cell receptor peptide; T cells; Vaccination therapy

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR PEPTIDE VACCINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CELL CLONE; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; VACCINATION;

EID: 0031007204     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00028-3     Document Type: Article

References (38)

1. Bellamy, A.S., Calder, V.L., Feldmann, M. and Davison, A.N. (1985) The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: Evidence for a key role of activated lymphocytes. Clin. Exp. Immunol. 61, 248-256.
2. Ben-Nun, A., Wekerle, H. and Cohen, I.R. (1981a) The rapid isolation of clonable antigen-specific T-lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195-199.
3. Ben-Nun, A., Wekerle, H. and Cohen, I.R. (1981b) Vaccination against EAE with T-lymphocyte lines and cells reactive against myelin basic protein. Nature 292, 60-61.
4. Bender, A., Ernst, N., Inflesias, A., Dornmair, K., Wekerle, H. and Hohfeld, R. (1995) T-cell receptor repertoire in polymyositis: Clonal expansion of autoaggressive CD8+ T-cells. J. Exp. Med. 181, 1863-1868.
5. Bourdette, D.N., Whitham, R.H., Chou, Y.K., Morrison, W.J., Atherton, J., Kenny, C., Liefeld, D., Hashim, G.A., Offner, H. and Vandenbark, A.A. (1994) Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J. Immunol. 152, 2510-2519.
6. Burns, F.R., Li, X., Shen, N., Offner, H., Chou, Y., Vandenbark, A.A. and Heber-Katz, E. (1989) Both rat and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα- and Vβ-chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169, 27-39.
7. Chang, J.C.C., Smith, L.R., Froning, K.J., Schwabe, B.J., Laxer, J.A., Caralli, L.L., Kurland, H.H., Karasek, M.A., Wilkinson, D.I., Carlo, D.J. and Brostoff, S.W. (1994) CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors Vβ3 and/or Vβ13.1 genes. Proc. Nat. Acad. Sci. USA 91, 9282-9286.
8. Chluba, J., Steeg, C., Becker, A., Wekerle, H. and Epplen, J.T. (1989) T-cell receptor β chain usage in myelin basic protein-specific rat T-lymphocytes. Eur. J. Immunol. 19, 279-284.
9. Chou, Y.K., Bourdette, D.N., Offner, H., Whitham, R., Wang, R.Y., Hashim, G.A. and Vandenbark, A.A. (1992) Frequency of T-cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38, 105-114.
10. Chou, Y.K., Buenafe, A.C., Dedrick, R., Morrison, W.J., Bourdette, D.N., Whitham, R., Atherton, J., Lane, J., Spoor, E., Hashim, G.A., Offner, H. and Vandenbark, A.A. (1994a) T-cell receptor Vβ gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T-cells from patients with multiple sclerosis. J. Neurosci. Res. 37, 169-181.
11. Chou, Y.K., Morrison, W.J., Weinberg, A.D., Dedrick, R., Whitham, R., Bourdette, D.N., Hashim, G., Offner, H. and Vandenbark, A.A. (1994b) Immunity to TCR peptides in multiple sclerosis. II. T-cell recognition of Vβ5.2 and Vβ6.1 CDR2 peptides. J. Immunol. 152, 2520-2529.
12. Gaur, A., Haspel, R., Mayer, J.P. and Fathman, C.G. (1993) Requirement for CD8+ cells in T-cell receptor peptide-induced clonal unresponsiveness. Science 259, 91-94.
13. Gold, D.P., Offner, H., Sun, D., Wiley, S., Vandenbark, A.A. and Wilson, D.B. (1991) Analysis of T-cell receptor β chains in Lewis rats with experimental allergic encephalomyelitis: Conserved CDR3 regions. J. Exp. Med. 174, 1467-1476.
14. Gold, D.P., Smith, R.A., Golding, A.B., Morgan E.E., Dafashy, T., Nelson J., Diveley, J., Laxer, J.A., Richieri, S.P., Carlo, D.J., Brostoff, S.W. and Wilson, D.B. (1997) Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCR Vβ6 CDR2 peptide. J. Neuroimmunol. 76, 29-38.
15. Grom, A., Thompson, S.D., Luyrink, L., Passo, M., Choi, E. and Glass, D.N. (1993) Dominant T-cell receptor β chain variable region Vβ14+ clones in juvenile rheumatoid arthritis. Proc. Nat. Acad. Sci. USA 90, 11104-11108.
16. Grunewald, J., Jeddi-Tehrani, M., Pisa, E., Janson, C.H., Andersson, R. and Wigzell, H. (1992) Analysis of Jβ gene segment usage by CD4+ and CD8+ human peripheral blood T-lymphocytes. Int. Immunol. 4, 643-650.
17. Hafler, D.A., Fox, D.A., Manning, M.E., Schlossman, S.F., Reinherz, E.L. and Weiner, H.L. (1985) In vivo activated T-lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N. Engl. J. Med. 312, 1405-1411.
18. Howell, M.D., Winters, S.T., Olee, T., Powell, H.C., Carlo, D.J. and Brostoff, S.W. (1989) Vaccination against experimental allergic encephalomyelitis with T-cell receptor peptides. Science 246, 668-669.
19. Kumar, V. and Sercarz, E. (1995) Immunodominant framework region 3 peptide from TCR Vβ8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154, 1941-1950.
20. Li, Y., Szabo, P. and Posnett, D.N. (1991) The genomic structure of human Vβ6 T-cell antigen receptor genes. J. Exp. Med. 174, 1537-1547.
21. Maniatis,T., Tritsch, E.F. and Sambrook, J. (1982) Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory, New York.
22. McFarlin, D.E. and MacFarland, H. (1982) Multiple sclerosis. N. Engl. J. Med. 307, 1183-1188.
23. Offner, H., Hashim, G. and Vandenbark, A.A. (1991) T-cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 251, 430-432.
24. Offner, H., Buenafe, A.C., Vainiene, M., Celnik, B., Weinberg, A.D., Gold, D.P., Hashim, G. and Vandenbark, A.A. (1993) Where, when and how to detect biased expression of disease-relevant Vβ genes in rats with experimental autoimmune encephalomyelitis. J. Immunol. 151, 506-517.
25. Oksenberg, J.R., Panzara, M.A., Begovich, A.B., Mitchell, D., Erlich, H.A., Murray, R.S., Shimonkevitz, R., Sherritt, R. M., Rothbard, J., Bernard, C.C.A. and Steinman, L. (1993). Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362, 68-70.
26. Paterson, P.Y. (1976) Experimental autoimmune (allergic) encephalomyelitis: Induction, pathogenesis and suppression. In: P.A. Miescher and H.J. Müller-Eberhard (Eds.), Textbook of Immunopathology, 2nd Ed. Grune and Stratton, New York, p. 179.
27. Paterson, P.Y. and Swanborg, R.H. (1988) In: M. Samter, D.W. Talmage, M.M. Frank, K.F. Austin and H.N. Claman (Eds.), Immunological Diseases, 4th Ed. Little Brown & Co., Boston, MA, p. 1877.
28. Poser, C.M., Paty, D.W., Scheinberg, L., MacDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H. and Tourtellotte, W.W. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 13, 227-231.
29. Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 78, 5453-5457.
30. Seboun, E, Robinson, M.A., Doolittle, T.H., Ciulla, T.A., Kindt, J.J. and Hauser, S.J. (1989). A susceptibility locus for multiple sclerosis is linked to the T-cell receptor β chain complex. Cell 57, 1095-1100.
31. Sun, D., Qin, Y., Chluba, J., Epplen, J.T. and Wekerle, H. (1988) Suppression of experimentally induced autoimmune encephalomyelitis by cytotoxic T-T interactions. Nature 332, 843-845.
32. Toyonaga, B., Yoshikai, Y., Vadasz, V., Chin, B. and Mak, T.W. (1985) Organization and sequences of the diversity, joining and constant region genes of the human T-cell receptor β chain. Proc. Natl. Acad. Sci. USA 82, 8624-8628.
33. Vandenbark, A.A., Hashim, G. and Offner, H. (1989) Immunization with a synthetic T-cell receptor V region peptide protects against EAE. Nature 341, 541-544.
34. Waksman, B.H. and Reynolds, W.E. (1984) Multiple sclerosis as a disease of immune regulation. Proc. Soc. Exp. Biol. Med. 175, 282-294.
35. Weyand, C.M., Schonberger, J., Oppitz, U., Hunder, N.N.H., Hicok, K.C. and Goronzy, J.J. (1994) Distinct vascular lesions in giant cell arteritis share identical T-cell clonotypes. J. Exp. Med. 179, 951-960.
36. Wilson, D.B. (1989) Idiotypic regulation of T-cells in graft-versus-host disease and autoimmunity. Immunol. Rev. 107, 159-177.
37. Wucherpfennig, K.W., Zhang, J., Witek, C., Matsui, M., Modabber, Y., Ota, K. and Hafler, D.A. (1994) Clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152, 5581-5592.
38. Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H.L. and Hafler, D.A. (1994) Increased frequency of interleukin-2 responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179, 973-984.